Testing the PD-1 Antibody, MK3475, Given With Ziv-aflibercept in Patients With Advanced Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Artios Pharma Ltd
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Frontier Medicines Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Beijing Biotech
National Cancer Institute (NCI)
Jules Bordet Institute
Centre Oscar Lambret
Eli Lilly and Company
PMV Pharmaceuticals, Inc
Mayo Clinic
Mayo Clinic
Tomsk National Research Medical Center of the Russian Academy of Sciences
National Institutes of Health Clinical Center (CC)
Taiho Oncology, Inc.
Kivu Bioscience Inc.
Federation Francophone de Cancerologie Digestive
Alterome Therapeutics, Inc.
Verastem, Inc.
Fudan University
Imugene Limited
Eli Lilly and Company
BicycleTx Limited
Huazhong University of Science and Technology
M.D. Anderson Cancer Center
Fudan University
M.D. Anderson Cancer Center
Centre Leon Berard
Coherus Oncology, Inc.
ViroMissile, Inc.
I-Mab Biopharma US Limited
Ohio State University Comprehensive Cancer Center
Pfizer
Astellas Pharma Inc
Cedars-Sinai Medical Center
Boston Scientific Corporation
Pfizer
Tizona Therapeutics, Inc
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
ALX Oncology Inc.
University of California, San Diego
Genentech, Inc.
Next Biomedical Co., Ltd.